About Reevax Pharma
Reevax Pharma is a company. Reevax Pharma offers products and services including XOIN® Tissue Adhesive and XOIN+ Combination Product.
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
- Legal Name Reevax Pharma Private Limited
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$226.67 K (USD)-5.44as on Mar 31, 2022
-
Net Profit
$16.5 K (USD)127.77as on Mar 31, 2022
-
EBITDA
$50.62 K (USD)44.71as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Reevax Pharma
Reevax Pharma offers a comprehensive portfolio of products and services, including XOIN® Tissue Adhesive and XOIN+ Combination Product.
A patented topical tissue adhesive is used for wound closure in surgeries, providing ease of application and reducing pain
A unique combination product is utilized for blocking bleeding gastric varices in the gastroenterology market
Funding Insights of Reevax Pharma
Detailed funding history for Reevax Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Reevax Pharma
Investment portfolio details for Reevax Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Reevax Pharma
Detailed financials for Reevax Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Reevax Pharma Comparisons
Peer comparison for Reevax Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Reevax Pharma
Detailed competitors of Reevax Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Reevax Pharma
Complete news archive for Reevax Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Reevax Pharma
Annual revenue of Reevax Pharma is $226.67K as on Mar 31, 2022.
Reevax Pharma Private Limited is described as a medical device manufacturer that was established in 2004, combining advanced technology with industrial experience. It is noted for developing patented tissue adhesives that facilitate painless wound closure and address surgical needs, thereby reducing pain and scarring. Quality is maintained through adherence to GMP and ISO standards, with a commitment to innovation in healthcare. The company is recognized for its contributions to enhanced patient care and global market presence in wound care products.
Reevax Pharma offers XOIN® Tissue Adhesive and XOIN+ Combination Product.